Genomic evidence of HMPV resurgence in Beijing:Clade B2 triggers the 2024 winter epidemic peakOA
With an unexpected increase of human metapneumovirus(hMPV)cases in northern China since late 2024,concerns arose whether novel hMPV variants triggered this epidemic.Utilizing the Beijing Respiratory Pathogen Surveillance System(RPSs),we conducted a genomic evolutionary analysis spanning 2014-2o24 and revealed genetic information for the strains thatcaused the high rates of hMPV outbreaks during this period.To clarify the epidemic drivers and evolutionary characteristics of the hMPV strains circulating in Beijing,phylogenetic,population dynamic and mutation analyses were performed using high-quality complete sequences from both this study and publicly available data.A total of 348 high-quality hMPV genomes were obtained by next-generation sequencing(NGS),all of which belonged to four known clades:A2b1,A2b2,B1,and B2.Before 2024,A2b2 predomi-nated in Beijing;however,a shift to clade B2 was observed starting in late 2024.In addition,a phylogenetically independent lineage I was identified in this study,accounting for 93.1% of B2 genomes collected since late 2024.Furthermore,we identified several unique nonsynonymous mutations in viruses within lineage I that may have phenotypic implications.Our findings indicate that lineage I of clade B2 was the major cause of the unusual increase in hMPV outbreaks in Beijing in late 2024,with no evidence of an emerging novel variant.Although our data were only restricted to samples from Beijing,the findings are likely representative of the hMPV surge across northern China in 2024,given city''s high population density and mobility.
Lu Kang;Fang Huang;Yi-Mo Deng;Geng Hu;Yiting Wang;Aihua Li;Hui Xie;Xiaofeng Wei;Yuling Han;Ming Luo;Ian G.Barr;George F.Gao;Liang Wang;Quanyi Wang
Beijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaWHO Collaborating Centre for Reference and Research on Influenza,VIDRL,Peter Doherty Institute for Infection and Immunity,Melbourne VIC 3000,Australia School of Biomedical Sciences,The University of Western Australia,Perth,Western Australia,WA 6009,AustraliaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,ChinaWHO Collaborating Centre for Reference and Research on Influenza,VIDRL,Peter Doherty Institute for Infection and Immunity,Melbourne VIC 3000,Australia Department of Microbiology and Immunology,University of Melbourne,Melbourne,VIC 3000,AustraliaCAS Key Laboratory of Pathogen Microbiology and Immunology,Institute of Microbiology,CAS-TWAS Center of Excellence for Emerging Infectious Diseases(CEEID),Chinese Academy of Sciences,Beijing 100101,ChinaCAS Key Laboratory of Pathogen Microbiology and Immunology,Institute of Microbiology,CAS-TWAS Center of Excellence for Emerging Infectious Diseases(CEEID),Chinese Academy of Sciences,Beijing 100101,ChinaBeijing Key Laboratory of Surveillance,Early Warning and Pathogen Research on Emerging Infectious Diseases,Beijing Center for Disease Prevention and Control,Beijing 100013,China School of Public Health,Capital Medical University,Beijing 100069,China Beijing Research Center for Respiratory Infectious Diseases,Beijing 100013,China
医药卫生
Human metapneumovirus(hMPV)GenomicsAcute respiratory tract infections(ARTIs)Next-generation sequencing(NGS)
《Virologica Sinica》 2026 (1)
P.48-57,10
supported by the National Key R&D Program of China(2022YFF1203203)the Capital''s Funds for Health Improvement and Research(grant number 2024-1G-3015)the Beijing Municipal Health Commission''s Funds for the High-qualified Public Health Professionals Development Project(Leading Professionals O110)the Beijing Natural Science Foundation(grant number L242051)the Science&Technology Fundamental Resources Investigation Program(2022FY100903).
评论